Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Alberta

$40,000.00

Single transmembrane domain insulin-like growth factor-II receptor and G protein: potential interaction and its significance in brain function

EF 2014-15

Résumé
The insulin-like growth factor-II (IGF-II) receptor is a single transmembrane glycoprotein containing a large extracellular domain and small cytoplasmic tail. The receptor interacts with the IGF-II and mannose 6-phosphate-bearing lysosomal enzymes via two distinct sites. A majority of the receptors are expressed within trans-Golgi network/endosomal compartments, where they divert newly synthesized lysosomal enzymes from the secretory pathway to endosomes and lysosomes. A subset of receptors located on the plasma membrane regulates endocytosis of secreted lysosomal enzymes, mediates internalization and degradation of IGF-II. Unlike intracellular trafficking, the role of the IGF-II receptor in the transmembrane signaling of IGF-II remains poorly understood. We have recently reported that the IGF-II receptor of the brain is coupled to a G protein and its activation by IGF-II or Leu27IGF-II, an analog that binds preferentially to the IGF-II receptor, potentiates acetylcholine release but decrease GABA release from the rat hippocampus by a G protein-sensitive pathway. Additionally, we observed that IGF-II receptors are associated with G protein-coupled receptor interacting protein beta-arrestin-2 and are translocated from detergent-resistant membrane to detergent-soluble membrane fractions following stimulation with agonist. These results led us to hypothesize that the single transmembrane domain IGF-II receptor in the brain is coupled to a G-protein and its activation can mediate specific biological responses by triggering G protein-linked intracellular signaling mechanism. To address this issue we propose i) to establish the specificity of the IGF-II receptor interaction with G protein/beta-arrestin-2, ii) to evaluate whether the IGF-II receptor interacts directly or indirectly with the G protein, iii) to determine the mechanisms by which IGF-II attenuates hippocampal GABA release and iv) to study alterations in the GABAergic and cholinergic systems in the brain of IGF-II receptor overexpressing transgenic mice. We believe that this study should not only provide evidence for the physiological relevance of IGF-II receptor in normal brain but it will also pave the way for a better understanding of its role in neurodegenerative diseases.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
203518-2011
Name nom
Kar, Satyabrata
Department département
Psychiatry
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2011
Award amount
40000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Partie
4
Nb partie
5
Application title
Single transmembrane domain insulin-like growth factor-II receptor and G protein: potential interaction and its significance in brain function
Keyword
NSERC
Application summary
The insulin-like growth factor-II (IGF-II) receptor is a single transmembrane glycoprotein containing a large extracellular domain and small cytoplasmic tail. The receptor interacts with the IGF-II and mannose 6-phosphate-bearing lysosomal enzymes via two distinct sites. A majority of the receptors are expressed within trans-Golgi network/endosomal compartments, where they divert newly synthesized lysosomal enzymes from the secretory pathway to endosomes and lysosomes. A subset of receptors located on the plasma membrane regulates endocytosis of secreted lysosomal enzymes, mediates internalization and degradation of IGF-II. Unlike intracellular trafficking, the role of the IGF-II receptor in the transmembrane signaling of IGF-II remains poorly understood. We have recently reported that the IGF-II receptor of the brain is coupled to a G protein and its activation by IGF-II or Leu27IGF-II, an analog that binds preferentially to the IGF-II receptor, potentiates acetylcholine release but decrease GABA release from the rat hippocampus by a G protein-sensitive pathway. Additionally, we observed that IGF-II receptors are associated with G protein-coupled receptor interacting protein beta-arrestin-2 and are translocated from detergent-resistant membrane to detergent-soluble membrane fractions following stimulation with agonist. These results led us to hypothesize that the single transmembrane domain IGF-II receptor in the brain is coupled to a G-protein and its activation can mediate specific biological responses by triggering G protein-linked intracellular signaling mechanism. To address this issue we propose i) to establish the specificity of the IGF-II receptor interaction with G protein/beta-arrestin-2, ii) to evaluate whether the IGF-II receptor interacts directly or indirectly with the G protein, iii) to determine the mechanisms by which IGF-II attenuates hippocampal GABA release and iv) to study alterations in the GABAergic and cholinergic systems in the brain of IGF-II receptor overexpressing transgenic mice. We believe that this study should not only provide evidence for the physiological relevance of IGF-II receptor in normal brain but it will also pave the way for a better understanding of its role in neurodegenerative diseases.